The procedure is especially effective when treating younger, low-risk patients. 

Researchers reported at TCT 2021 that survival was 100% after 30 days.

Overall, researchers found, this method was “simple, reproducible, safe and effective.”

Age, diabetes and smoking were all also found to be “significant predictors” of reduced valve durability among SAVR patients.

Early valve replacement was associated with improved outcomes in a new study published in Circulation.

Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.

Should patients be undergoing SAVR earlier? Is poor follow-up care partially to blame? 

The study's authors said that policies should be put in place to provide better support for these individuals.